John Vandermosten

Carl Byrnes

Ryan Zimmerman

Ramakanth Swayampakula

Swayampakula Ramakanth

Vadim Alexandre Khalil

- **Spectral AI, Inc.** reported **Q2 2025** research and development revenue of **$5.1 million** and total first-half revenue of **$11.8 million**, with a cash position of **$10.5 million**.  **[1833498_20250826LN59222:2]** 
- The company completed the submission of its De Novo application to the **FDA** in **June 2025** for its DeepView® System, an AI-powered diagnostic tool for wound care, with initial applications for burns.  **[1833498_20250826LN59222:2]** 
- **Spectral AI** reiterated its **2025 revenue guidance** of approximately **$21.5 million**.  **[1833498_20250826LN59222:2]**

Spectral AI (MDAI)